Today: 21 May 2026
Arm stock set for earnings week after CEO sale notice and chip selloff

Arm stock set for earnings week after CEO sale notice and chip selloff

New York, Feb 1, 2026, 18:26 EST — Market closed.

  • Arm’s U.S.-listed sponsored ADRs dropped 2.8% in the last session, closing at $105.36.
  • A filing revealed CEO Rene Haas intends to sell a small number of shares under SEC Rule 144.
  • Traders are turning to Arm’s earnings report on Feb. 4 for new clues on the market’s next move.

Arm’s U.S.-listed sponsored ADRs dropped 2.8% to $105.36 on Friday, wrapping up a tough day for chip stocks. The shares remain in the spotlight as the company gears up to release its quarterly results this week.

The timing is crucial as Arm Holdings will release its fiscal third-quarter results on Feb. 4, after the market closes, followed by a webcast at 17:00 Eastern (14:00 Pacific) to discuss the numbers and outlook.

Arm’s decline followed a wider selloff in semiconductors on Friday. The PHLX Semiconductor Index dropped 3.9% by the close.

Investors reacted to a shift in rate outlooks following Donald Trump’s choice of Kevin Warsh to replace Jerome Powell as Federal Reserve chair, amid earnings reports and a stronger-than-expected inflation figure. “Markets are calibrating” to the nomination, noted Michael Hans, chief investment officer at Citizens Wealth. Reuters

Arm CEO Rene Haas intends to offload 6,152 American depositary shares, worth roughly $654,000, according to a filing. The sale is set to go through Fidelity Brokerage Services around Jan. 30.

A Form 144 notifies the U.S. Securities and Exchange Commission that an insider plans to sell shares under Rule 144; it doesn’t confirm the sale has actually taken place.

Arm focuses on designing and licensing chip technology instead of manufacturing processors. It earns licensing fees and ongoing royalties based on the chips its customers produce using Arm’s architecture.

Looking ahead to the week, all eyes turn to guidance. Investors want to see if Arm shifts its outlook on licensing demand and royalty trends, especially for high-end chips used in servers and AI tasks. They’ll also watch for clues on how quickly smartphone and PC upgrades are moving.

But the setup works both ways. If bond yields remain volatile and risk appetite fades, even strong results might not boost the stock. A cautious outlook or a more muted licensing update could deepen the selling pressure.

Markets reopen Monday. The next major event for Arm comes Wednesday, with results and outlook due Feb. 4 after the close.

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Intel stock price: INTC ends Friday lower — what to watch before Monday’s open
Previous Story

Intel stock price: INTC ends Friday lower — what to watch before Monday’s open

Marvell stock slides to $78.92 — what MRVL investors watch as payrolls, tech earnings loom
Next Story

Marvell stock slides to $78.92 — what MRVL investors watch as payrolls, tech earnings loom

Go toTop